Our findings confirm that high Tiam1 expression in the carcinomas of the oral cavity, glottis, and supraglottic larynx predicts poor clinical outcomes, suggesting that Tiam1 might be a new molecular biomarker of this disease. The gene discussed is TIAM1; the disease is carcinoma.